Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SWEDISH PERFUSION AKTIEBOLAG
AB
Active
Org 5563017226
Dalagatan 47, 113 31
Stockholm
Buying and selling of own real estate
· NACE 6811
Est. 1987
0 employees
Watchlist
Share
Sweden
/
Companies
/
Buying and selling of own real estate
/
SWEDISH PERFUSION AKTIEBOLAG
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
243
250
215
213
226
Staff expenses
—
−29
−23
−30
−25
EBITDA
124
−3
124
97
132
Depreciation & amort.
−7
−7
−7
−7
−7
EBIT
117
−11
117
90
124
Net financials
−13
−22
−30
−30
−22
Profit before tax
103
−32
87
45
82
Tax
−21
—
−11
−9
−17
Net profit
82
−32
75
36
65
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 379
3 338
3 449
3 519
2 929
Equity
1 310
1 277
1 352
1 400
1 465
Long-term debt
2 030
2 030
2 030
2 030
1 308
Short-term debt
40
31
67
79
121
Total debt
2 070
2 061
2 097
2 109
1 429
Financial ratios
5-year trend
EBITDA margin
58.3%
This company
15.8%
Market median
+269% vs market
2021
2025
Equity ratio
50.0%
This company
38.2%
Market median
+31% vs market
2021
2025
Return on equity
4.4%
This company
18.4%
Market median
-76% vs market
2021
2025
Net profit margin
28.8%
This company
8.1%
Market median
+256% vs market
2021
2025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2021
2025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on SWEDISH PERFUSION AKTIEBOLAG
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
